This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]
U.S. Food and Drug Administration
rule

Cancer Liaison Program

The Food and Drug Administration's Cancer Liaison Program in the Office of Special Health Issues answers questions directed to FDA by patients, their friends and family members and patient advocates about therapies for life-threatening diseases.

Cancer Drug Development Patient Consultant Program

This program incorporates the perspective of cancer patient advocates into the drug development process allowing them an opportunity to participate in the FDA drug review regulatory process.

Cancer Patient Representative Program

This program was charged with developing a process for recruiting, assessing, and selecting patient representatives to serve as members of cancer-related advisory committees

Oncology Tools

information related to cancer and approved cancer drug therapies

ClinicalTrials.gov

Provides patients, family members and members of the public current information about clinical research studies, and basic information about clinical trials

National Cancer Institute/NIH

National Institute of Health information about cancer research, cancer statistics, and other cancer-related information

Other Government Resources

News Releases

News releases specifically related to cancer-related FDA actions, such as new drug approvals.

Advisory Committees

List of FDA advisory committees for drugs, including oncologic drugs.

Meetings

There are no meetings scheduled at this time.

Publications

Cancer information for consumers written by the Cancer Liaison Staff and other FDA sources.

rule

Contact Us

rule